| Name | Title | Contact Details |
|---|
Regulatory Presentation Management is a Durham, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Washington Radiology Assoc is a Sterling, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HMA is a regional third-party healthcare benefits administrator, dedicated to helping the companies we service improve their employee and family health and wellbeing through customized benefits plans and innovative support services.
Pride Mobility Products® Corporation is the worlds leading designer and manufacturer of mobility products including Jazzy® Power Chairs, Go-Go® Travel Mobility, Pride® Mobility Scooters, Pride® Power Lift Recliners, and Pride® Lifts and Ramps. The Pride family of companies also includes Quantum Rehab®, a leader in complex rehab power chairs with the Q6 Edge® 2.0, 4Front™, and Q6 Series of power bases, TRU-Balance® 3 Power Positioning Systems, and Q-Logic 3 Advanced Drive Controls, as well as Stealth Products®, the foremost manufacturer of positioning components. Headquartered in Exeter, Pennsylvania, Pride also has operations in Australia, Canada, China, Italy, the Netherlands, New Zealand, and the United Kingdom. Pride is dedicated to providing expertly designed, engineered, and tested products incorporating technologically innovative features enabling consumers to achieve the highest quality of life and mobility goals. Pride helps millions of people live their lives to the fullest by creating the best personal mobility products in the world. Pride’s products serve the widest range of mobility needs, with a family of brands that are industry leaders in changing lives. Our employees are treated with respect and provided with an equal opportunity to contribute to the success of our company and their own personal growth. Pride Mobility Products Corporation is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected Veteran status.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.